Clorox rated 'Buy' with 44.7% potential return, supported by dividends and growth despite short-term challenges.

Clorox (CLX) is rated a 'Buy' at $87.1, showing a 37% undervaluation and a potential total return of 44.7%. The company benefits from a strong dividend yield and a conservative growth outlook. Short-term challenges include ERP system transition, supply chain costs, and high oil prices, but these are expected to ease. Long-term growth is supported by the acquisition of GOJO and international expansion. Although the dividend payout ratio is high at 89% for FY26, gradual earnings growth and modest dividend increases should normalize this to 60-65% over five years. A bull Put Spread options strategy is suggested for investors seeking up to 51% ROI with limited downside risk, making Clorox a defensive investment choice.